
With a powerhouse team of seasoned business development executives, we bring over 50 years of combined experience to the table. Our expertise spans:

R&D Collaborations

In- and Out-licensing

Joint Ventures

Mergers and Acquisitions

Sinogen Bio was founded by Jung Lee and Qiming Venture Partners.
November 2021
Vetted 300+ assets. Established partners with 40+ Chinese biotech companies. Managing 20+ assets across therapeutic areas.
2022 - 2025

Closed 2 deals worth >$2B biobucks.
Jan 2024

Sinogen Bio was rebranded to Conexus Bio.
June 2024

Closed 1 deal worth >$700M biobucks.
June 2025
Expanding our biotech coverage.
2026 +

